These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 25815135)

  • 1. Neural stem cells could serve as a therapeutic material for age-related neurodegenerative diseases.
    Suksuphew S; Noisa P
    World J Stem Cells; 2015 Mar; 7(2):502-11. PubMed ID: 25815135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Stem Cell Therapies in the Treatment of Neurodegenerative Diseases.
    Jayaprakash B; Savira M; Mahmood AAR; Prasanna M
    Curr Stem Cell Res Ther; 2024 May; ():. PubMed ID: 38778595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neural stem cell-based treatment for neurodegenerative diseases.
    Kim SU; Lee HJ; Kim YB
    Neuropathology; 2013 Oct; 33(5):491-504. PubMed ID: 23384285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Embryonic stem cell-derived L1 overexpressing neural aggregates enhance recovery in Parkinsonian mice.
    Cui YF; Hargus G; Xu JC; Schmid JS; Shen YQ; Glatzel M; Schachner M; Bernreuther C
    Brain; 2010 Jan; 133(Pt 1):189-204. PubMed ID: 19995872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amelioration of Huntington's disease phenotype in astrocytes derived from iPSC-derived neural progenitor cells of Huntington's disease monkeys.
    Cho IK; Yang B; Forest C; Qian L; Chan AWS
    PLoS One; 2019; 14(3):e0214156. PubMed ID: 30897183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pluripotent stem cell strategies for rebuilding the human brain.
    Limone F; Klim JR; Mordes DA
    Front Aging Neurosci; 2022; 14():1017299. PubMed ID: 36408113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of stem cells in regenerative medicine for Parkinson's and Huntington's Diseases.
    Lescaudron L; Naveilhan P; Neveu I
    Curr Med Chem; 2012; 19(35):6018-35. PubMed ID: 22963567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stem cells as therapeutics for neurodegenerative disorders?
    Mattson MP
    Expert Rev Neurother; 2001 Nov; 1(2):267-73. PubMed ID: 19811037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring the Role of Stem Cell Therapy in Treating Neurodegenerative Diseases: Challenges and Current Perspectives.
    Puranik N; Arukha AP; Yadav SK; Yadav D; Jin JO
    Curr Stem Cell Res Ther; 2022; 17(2):113-125. PubMed ID: 35135462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic potential of neurogenesis for prevention and recovery from Alzheimer's disease: allopregnanolone as a proof of concept neurogenic agent.
    Brinton RD; Wang JM
    Curr Alzheimer Res; 2006 Jul; 3(3):185-90. PubMed ID: 16842093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic potential of stem cells for treatment of neurodegenerative diseases.
    Ahmadian-Moghadam H; Sadat-Shirazi MS; Zarrindast MR
    Biotechnol Lett; 2020 Jul; 42(7):1073-1101. PubMed ID: 32342435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current status and future prospects of stem cell therapy in Alzheimer's disease.
    Zhang FQ; Jiang JL; Zhang JT; Niu H; Fu XQ; Zeng LL
    Neural Regen Res; 2020 Feb; 15(2):242-250. PubMed ID: 31552889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Translation of stem cell therapy for neurological diseases.
    Schwarz SC; Schwarz J
    Transl Res; 2010 Sep; 156(3):155-60. PubMed ID: 20801412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stem cell therapy in neurodegenerative diseases: From principles to practice.
    Sakthiswary R; Raymond AA
    Neural Regen Res; 2012 Aug; 7(23):1822-31. PubMed ID: 25624807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stem cell-based cell therapy in neurological diseases: a review.
    Kim SU; de Vellis J
    J Neurosci Res; 2009 Aug; 87(10):2183-200. PubMed ID: 19301431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentials of ES cell therapy in neurodegenerative diseases.
    Srivastava AS; Malhotra R; Sharp J; Berggren T
    Curr Pharm Des; 2008; 14(36):3873-9. PubMed ID: 19128238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The potential of alternate sources of cells for neural grafting in Parkinson's and Huntington's disease.
    Drouin-Ouellet J
    Neurodegener Dis Manag; 2014; 4(4):297-307. PubMed ID: 25313986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opportunities and challenges for the use of induced pluripotent stem cells in modelling neurodegenerative disease.
    Wu YY; Chiu FL; Yeh CS; Kuo HC
    Open Biol; 2019 Jan; 9(1):180177. PubMed ID: 30958120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biology and clinical application of neural stem cells.
    Shimazaki T
    Horm Res; 2003; 60 Suppl 3():1-9. PubMed ID: 14671388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Organotypic cultures as tools for optimizing central nervous system cell therapies.
    Daviaud N; Garbayo E; Schiller PC; Perez-Pinzon M; Montero-Menei CN
    Exp Neurol; 2013 Oct; 248():429-40. PubMed ID: 23899655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.